Current filters:  
Healthcare
Canada
WeirFoulds LLP
In an effort to move towards an open market for cannabis, the Ontario Government recently launched an online consultation to ask the public, businesses, health sector, and other stakeholders ...
China
DeHeng Law Offices
疫情下药品进口法律法规简析
Mexico
Sanchez Devanny
Mexican Ministry of Health issues fast track approval process for products approved in other jurisdictions, and rules regarding import of drug products without need for a Mexican marketing ...
UK
Cooley LLP
The update provides further clarity on the UK's status in the licensing process now that Brexit has taken place.
United States
Holland & Knight
Then, by submitting false claims to Medicare and other federal health programs, the defendants knowingly or recklessly presented false claims for payment to the government in violation of the FCA.
Holland & Knight
he failure to comply with the rules may result in citation of the facility for a deficiency and the imposition of a civil penalty.
Foley & Lardner
On February 21, 2020, the Personalized Medicine Coalition (PMC) released its annual "Personalized Medicine At FDA: The Scope and Significance of Progress in 2019" (Report)
DLA Piper
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape
Shook, Hardy & Bacon L.L.P.
A Florida federal court has dismissed a lawsuit alleging that Bacardi U.S.A.'s Bombay Sapphire contains...
Shook, Hardy & Bacon L.L.P.
Miyoko's Kitchen Inc. has filed a lawsuit asserting that California infringed its First Amendment right to free speech by requiring the removal...
Reed Smith
It seems so obvious as not to require a citation – but this is the Drug and Device Law Blog, so we'll provide some anyway.
Squire Patton Boggs LLP
In MSPA Claims 1, LLC v. Kingsway Amigo Ins. Co., the 11th Circuit was tasked with answering the question of whether 42 U.S.C. § 1395y(b)(2)(B)(vi)...
Dickinson Wright PLLC
In 2019, Michigan enacted amendments to the No-Fault Act (the "Act"), MCL 500.3101 et seq., that will affect the way health care practitioners provide services and are compensated.
McDermott Will & Emery
Digital health companies are producing innovative products at a rapidly accelerating pace and experiencing a boom in investments and demand as the regulatory environment
Buchanan Ingersoll & Rooney PC
Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, the challenges he encounters
Foley Hoag LLP
The Centers for Medicare & Medicaid Services (CMS) suffered a big loss in court last week. The United States Court of Appeals for the D.C. Circuit upheld a lower...
Hogan Lovells
The U.S. Food and Drug Administration (FDA) has released the third and final installment of its Draft Guidance to support compliance with the Mitigation...
Foley & Lardner
How are businesses across the health care and life sciences spectrum collaborating to capitalize on the commercial promise of personalized medicine.
Reed Smith
This is a quick-hit post bringing you two first-of-their-kind orders on proving causation in cases alleging inadequate drug or medical device warnings.
Reed Smith
We've discussed before how we expect genetic testing of plaintiffs to become routine in prescription medical product liability litigation.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media